These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human β₂-adrenergic receptor. Kittanakom S; Barrios-Rodiles M; Petschnigg J; Arnoldo A; Wong V; Kotlyar M; Heisler LE; Jurisica I; Wrana JL; Nislow C; Stagljar I Biochem Biophys Res Commun; 2014 Mar; 445(4):746-56. PubMed ID: 24561123 [TBL] [Abstract][Full Text] [Related]
67. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism. Dalton JA; Lans I; Giraldo J BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715 [TBL] [Abstract][Full Text] [Related]
68. Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. West GM; Chien EY; Katritch V; Gatchalian J; Chalmers MJ; Stevens RC; Griffin PR Structure; 2011 Oct; 19(10):1424-32. PubMed ID: 21889352 [TBL] [Abstract][Full Text] [Related]
72. Detergent- and phospholipid-based reconstitution systems have differential effects on constitutive activity of G-protein-coupled receptors. Staus DP; Wingler LM; Pichugin D; Prosser RS; Lefkowitz RJ J Biol Chem; 2019 Sep; 294(36):13218-13223. PubMed ID: 31362983 [TBL] [Abstract][Full Text] [Related]
73. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. Bhattacharya S; Hall SE; Vaidehi N J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482 [TBL] [Abstract][Full Text] [Related]
74. Energy Landscapes Reveal Agonist Control of G Protein-Coupled Receptor Activation via Microswitches. Fleetwood O; Matricon P; Carlsson J; Delemotte L Biochemistry; 2020 Feb; 59(7):880-891. PubMed ID: 31999436 [TBL] [Abstract][Full Text] [Related]
75. Position of transmembrane helix 6 determines receptor G protein coupling specificity. Rose AS; Elgeti M; Zachariae U; Grubmüller H; Hofmann KP; Scheerer P; Hildebrand PW J Am Chem Soc; 2014 Aug; 136(32):11244-7. PubMed ID: 25046433 [TBL] [Abstract][Full Text] [Related]
76. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
77. Structural insights into binding specificity, efficacy and bias of a β Masureel M; Zou Y; Picard LP; van der Westhuizen E; Mahoney JP; Rodrigues JPGLM; Mildorf TJ; Dror RO; Shaw DE; Bouvier M; Pardon E; Steyaert J; Sunahara RK; Weis WI; Zhang C; Kobilka BK Nat Chem Biol; 2018 Nov; 14(11):1059-1066. PubMed ID: 30327561 [TBL] [Abstract][Full Text] [Related]
78. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Yao XJ; Vélez Ruiz G; Whorton MR; Rasmussen SG; DeVree BT; Deupi X; Sunahara RK; Kobilka B Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9501-6. PubMed ID: 19470481 [TBL] [Abstract][Full Text] [Related]
79. Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region. Kofuku Y; Ueda T; Okude J; Shiraishi Y; Kondo K; Maeda M; Tsujishita H; Shimada I Nat Commun; 2012; 3():1045. PubMed ID: 22948827 [TBL] [Abstract][Full Text] [Related]
80. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor. Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]